Ul solutions CEO Jennifer Scanlon sells $920,799 in company stock

UL Solutions (ULS) insider Jennifer F. Scanlon sold 12,500 shares for $920,799 on Sept. 1, 2026 under a 10b5-1 plan, at weighted-average prices of $73.5183 (10,495 shares) and $74.4266 (2,005 shares). Separately, ULS’s Q2 2026 results beat expectations with adjusted EPS of $0.59 vs $0.51 and revenue of $816M, while adjusted EBITDA reached a record $219M and margin expanded to 26.8%. Despite the earnings upside, the stock is down ~9.6% over six months (~31% vs the 52-week high), reflecting investor concerns about future spending and margin outlook.

Analysis

The insider sale is low-signal because it was pre-programmed and small relative to the CEO’s remaining exposure; the market should not treat it as a conviction event. The real issue is whether the current multiple already discounts a future step-up in reinvestment. If investors believe margin expansion is peaking, ULS can stay range-bound even with decent execution, because the next leg of upside requires proof that spending is driving durable share gains rather than just preserving growth.

Second-order, ULS is a useful read-through on quality industrial services and compliance spending. Sustained organic growth with expanding EBITDA margins would imply end-market resilience and support adjacent testing/inspection names, while a guide to heavier investment would pressure the whole “high-quality compounder” cohort by forcing a debate about peak margins versus duration. The lower-rate tape helps the stock only if fundamentals keep confirming the growth story; otherwise, falling yields merely slow the de-rating.

Contrarian view: the consensus may be too focused on the beat and too little on the fact that the rerating case now depends on forward revisions, not past execution. The 29% upside case likely assumes the market re-anchors to a premium multiple; that is fragile if the next quarter shows incremental spend with no acceleration in earnings power. This is a stock to own on evidence, not on insider-sale noise.

Key Decisions for Investors

• No action on the insider sale itself; treat ULS as a watch item into next earnings. Falsifier for the bullish case: any guide-down to margin/opex or organic growth slipping below mid-single digits.
• Starter long ULS only on a 5-7% pullback from current levels, or after management confirms that added spending is not compressing EBITDA margin. Use the next print as the catalyst; target 10-15% upside, stop if forward margin guidance is cut.
• Relative-value: long ULS / short XLI if rates keep easing and ULS holds growth above 5% organically. This expresses a quality-duration view while hedging broad industrial beta; exit if ULS underperforms XLI by ~5% on an earnings reaction.
• If the stock rallies into the next update without a better margin outlook, consider a bearish put spread for the earnings window rather than outright shorting. The thesis only works if the market’s multiple expansion outruns fundamental revision.